Prrt: What We Know, Special Considerations & Clinical Trials With Dr. Strosberg Jan 11, 2024

"PRRT: What We Know, Special Considerations & Clinical Trials" with Dr. Strosberg • Jan 11, 2024

Peptide Receptor Radionuclide Therapy (PRRT)

Carcinoid Cancer Foundation

What Is PRRT (Peptide Receptor Radionuclide Therapy) for Neuroendocrine Carcinoma?

Medical-Question

Somatostatin Analogs and PRRT: Treatment Considerations

The Latest in PRRT • Dr. Carina Mari Aparici • 2023 LACNETS Patient Education Conference

Improving PRRT for Neuroendocrine Tumors (NETs)

Who is a Good Candidate for PRRT (Peptide Receptor Radionuclide Therapy) with Jonathan Strosberg, MD

Carcinoid Cancer Foundation

Prof John Buscombe - The evidence for PRRT

British Nuclear Medicine Society

PRRT Therapy Basics and New Developments Brief by Dr. Aman Chauhan

PRRT (Peptide Receptor Radionuclide Therapy) with Jonathan Strosberg, MD

Carcinoid Cancer Foundation

PRRT Treatment Neuroendocrine Tumors

The Surgical Scholar

NET Patient Story: Re-treatment with PRRT (salvage PRRT)

How PRRT Can Improve Care for Neuroendocrine Tumor Patients

PRRT for NETs - Facts vs Fiction, by Prof. Rod Hicks

Neuroendocrine Cancer New Zealand

How do you determine whether PRRT is the treatment of choice for your condition?

Nuclear Medicine Therapy

Peptide receptor radionuclide therapy (PRRT) Explainer V2

NeuroEndocrine Cancer Australia

Combining PRRT with Targeted Therapy

PRRT Sequencing and the Future of Neuroendocrine Tumor Treatments with Jonathan Strosberg, MD

Carcinoid Cancer Foundation